Cochrane Systematic Review: Blood transfusion for treating malarial anaemia
Meremikwu M, Smith HJ
Meremikwu M, Smith HJ
OBJECTIVES: This review evaluates the effects of routine blood transfusion for severe anaemia on death and adverse outcomes in malarious areas.
OBJECTIVES: This review evaluates the effects of routine blood transfusion for severe anaemia on death and adverse outcomes in malarious areas.
Cochrane Systematic Review: Neonatal screening for sickle cell disease
Lees CM, Davies S, Dezateux C
Lees CM, Davies S, Dezateux C
OBJECTIVES: To assess whether there is evidence that neonatal screening for sickle cell disease rather than symptomatic diagnosis reduces adverse short and long term outcomes for those in whom the disease is detected, without adverse outcomes in the population screened.
OBJECTIVES: To assess whether there is evidence that neonatal screening for sickle cell disease rather than symptomatic diagnosis reduces adverse short and long term outcomes for those in whom the disease is detected, without adverse outcomes in the population screened.
Cochrane Systematic Review: Blood transfusion for preventing stroke in people with sickle cell disease
Wang WC, Dwan K
Wang WC, Dwan K
OBJECTIVES: To assess risks and benefits of chronic blood transfusion regimens in people with sickle cell disease to prevent first stroke or recurrences.
OBJECTIVES: To assess risks and benefits of chronic blood transfusion regimens in people with sickle cell disease to prevent first stroke or recurrences.
Cochrane Systematic Review: Antibiotics for treating community acquired pneumonia in people with sickle cell disease
Mart-Carvajal AJ, Conterno LO
Mart-Carvajal AJ, Conterno LO
OBJECTIVES: To determine the efficacy and safety of the antibiotic treatment approaches (monotherapy or combined) for people with sickle cell disease suffering from community-acquired pneumonia.
OBJECTIVES: To determine the efficacy and safety of the antibiotic treatment approaches (monotherapy or combined) for people with sickle cell disease suffering from community-acquired pneumonia.
Cochrane Systematic Review: Inhaled nitric oxide for acute chest syndrome in people with sickle cell disease
Al Hajeri A, Serjeant GR, Fedorowicz Z
Al Hajeri A, Serjeant GR, Fedorowicz Z
OBJECTIVES: To assess the effectiveness of inhaled nitric oxide for treating acute chest syndrome by comparing improvement in symptoms and clinical outcomes against standard care.
OBJECTIVES: To assess the effectiveness of inhaled nitric oxide for treating acute chest syndrome by comparing improvement in symptoms and clinical outcomes against standard care.
Cochrane Systematic Review: Blood transfusions for treating acute chest syndrome in people with sickle cell disease
Alhashimi D, Fedorowicz Z, Alhashimi F, Dastgiri S
Alhashimi D, Fedorowicz Z, Alhashimi F, Dastgiri S
OBJECTIVES: To assess the effectiveness of blood transfusions, simple and exchange, for treating ACS by comparing improvement in symptoms and clinical outcomes against standard care.
OBJECTIVES: To assess the effectiveness of blood transfusions, simple and exchange, for treating ACS by comparing improvement in symptoms and clinical outcomes against standard care.
Cochrane Systematic Review: Vitamin A supplementation during pregnancy for maternal and newborn outcomes
van den Broek N, Dou L, Othman M, Neilson JP, Gates S, Glmezoglu AM
van den Broek N, Dou L, Othman M, Neilson JP, Gates S, Glmezoglu AM
OBJECTIVES: To review the effects of supplementation of vitamin A, or one of its derivatives, during pregnancy, alone or in combination with other vitamins and micronutrients, on maternal and newborn clinical outcomes.
OBJECTIVES: To review the effects of supplementation of vitamin A, or one of its derivatives, during pregnancy, alone or in combination with other vitamins and micronutrients, on maternal and newborn clinical outcomes.
Cochrane Systematic Review: Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease
Sasongko TH, Nagalla S, Ballas SK
Sasongko TH, Nagalla S, Ballas SK
OBJECTIVES: To determine the effectiveness of ACE inhibitor administration in people with sickle cell disease for decreasing intraglomerular pressure, microalbuminuria and proteinuria and to to assess the safety of ACE inhibitors as pertains to their adverse effects.
OBJECTIVES: To determine the effectiveness of ACE inhibitor administration in people with sickle cell disease for decreasing intraglomerular pressure, microalbuminuria and proteinuria and to to assess the safety of ACE inhibitors as pertains to their adverse effects.
Cochrane Systematic Review: Blood transfusion for treating malarial anaemia
Meremikwu M, Smith HJ
Meremikwu M, Smith HJ
OBJECTIVES: This review evaluates the effects of routine blood transfusion for severe anaemia on death and adverse outcomes in malarious areas.
OBJECTIVES: This review evaluates the effects of routine blood transfusion for severe anaemia on death and adverse outcomes in malarious areas.
Cochrane Systematic Review: Neonatal screening for sickle cell disease
Lees CM, Davies S, Dezateux C
Lees CM, Davies S, Dezateux C
OBJECTIVES: To assess whether there is evidence that neonatal screening for sickle cell disease rather than symptomatic diagnosis reduces adverse short and long term outcomes for those in whom the disease is detected, without adverse outcomes in the population screened.
OBJECTIVES: To assess whether there is evidence that neonatal screening for sickle cell disease rather than symptomatic diagnosis reduces adverse short and long term outcomes for those in whom the disease is detected, without adverse outcomes in the population screened.
Cochrane Systematic Review: Blood transfusion for preventing stroke in people with sickle cell disease
Wang WC, Dwan K
Wang WC, Dwan K
OBJECTIVES: To assess risks and benefits of chronic blood transfusion regimens in people with sickle cell disease to prevent first stroke or recurrences.
OBJECTIVES: To assess risks and benefits of chronic blood transfusion regimens in people with sickle cell disease to prevent first stroke or recurrences.
Cochrane Systematic Review: Antibiotics for treating community acquired pneumonia in people with sickle cell disease
Mart-Carvajal AJ, Conterno LO
Mart-Carvajal AJ, Conterno LO
OBJECTIVES: To determine the efficacy and safety of the antibiotic treatment approaches (monotherapy or combined) for people with sickle cell disease suffering from community-acquired pneumonia.
OBJECTIVES: To determine the efficacy and safety of the antibiotic treatment approaches (monotherapy or combined) for people with sickle cell disease suffering from community-acquired pneumonia.
Cochrane Systematic Review: Inhaled nitric oxide for acute chest syndrome in people with sickle cell disease
Al Hajeri A, Serjeant GR, Fedorowicz Z
Al Hajeri A, Serjeant GR, Fedorowicz Z
OBJECTIVES: To assess the effectiveness of inhaled nitric oxide for treating acute chest syndrome by comparing improvement in symptoms and clinical outcomes against standard care.
OBJECTIVES: To assess the effectiveness of inhaled nitric oxide for treating acute chest syndrome by comparing improvement in symptoms and clinical outcomes against standard care.
Cochrane Systematic Review: Blood transfusions for treating acute chest syndrome in people with sickle cell disease
Alhashimi D, Fedorowicz Z, Alhashimi F, Dastgiri S
Alhashimi D, Fedorowicz Z, Alhashimi F, Dastgiri S
OBJECTIVES: To assess the effectiveness of blood transfusions, simple and exchange, for treating ACS by comparing improvement in symptoms and clinical outcomes against standard care.
OBJECTIVES: To assess the effectiveness of blood transfusions, simple and exchange, for treating ACS by comparing improvement in symptoms and clinical outcomes against standard care.
Cochrane Systematic Review: Vitamin A supplementation during pregnancy for maternal and newborn outcomes
van den Broek N, Dou L, Othman M, Neilson JP, Gates S, Glmezoglu AM
van den Broek N, Dou L, Othman M, Neilson JP, Gates S, Glmezoglu AM
OBJECTIVES: To review the effects of supplementation of vitamin A, or one of its derivatives, during pregnancy, alone or in combination with other vitamins and micronutrients, on maternal and newborn clinical outcomes.
OBJECTIVES: To review the effects of supplementation of vitamin A, or one of its derivatives, during pregnancy, alone or in combination with other vitamins and micronutrients, on maternal and newborn clinical outcomes.
Cochrane Systematic Review: Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease
Sasongko TH, Nagalla S, Ballas SK
Sasongko TH, Nagalla S, Ballas SK
OBJECTIVES: To determine the effectiveness of ACE inhibitor administration in people with sickle cell disease for decreasing intraglomerular pressure, microalbuminuria and proteinuria and to to assess the safety of ACE inhibitors as pertains to their adverse effects.
OBJECTIVES: To determine the effectiveness of ACE inhibitor administration in people with sickle cell disease for decreasing intraglomerular pressure, microalbuminuria and proteinuria and to to assess the safety of ACE inhibitors as pertains to their adverse effects.